Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation. [Prescrire Int] Journal article

Title	Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
Source	Prescrire Int 2009 Oct; 18(103):205.
Abstract	There is no firm evidence that patients with breakthrough cancer pain respond better to fentanyl effervescent buccal than to the "lollipop" formulation.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19882786

Advertise on this site.